15 completed, 2 terminated, 1 unknown. 8 Not applicable, 6 Phase 4, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 7, Terminated 1 |
| Phase 4 | 6 | Completed 5, Terminated 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Enzymotec: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Milk Sample Composition in Israeli Mothers and Correlation With Their Diet Breast Milk Collection | Completed | Enzymotec | 120 | 2015-10-01 | 2018-02-05 | |
| Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment Vayarin, Placebo - ADHD | Completed | Icahn School of Medicine at Mount Sinai | 107 | 2015-05-01 | 2017-03-27 | |
| Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD) Vayarin®, Placebo - Attention Deficit Hyperactivity Disorder (ADHD) | Not applicable | Completed | Enzymotec | 171 | 2014-10-01 | 2018-04-11 |
| Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment Phosphatidylserine, Placebo - Mild Cognitive Impairment | Not applicable | Terminated | Enzymotec | 97 | 2014-09-01 | 2018-02-05 |
| An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD) Medical Food : Vayarin_005, Placebo - Autistic Disorder | Not applicable | Completed | Enzymotec | 56 | 2014-08-01 | 2018-04-11 |
| The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels Omega-3 acid ethyl esters, Phytosterol esters of omega-3 - Patients With Hypertriglyceridemia | Not applicable | Completed | Enzymotec | 201 | 2012-10-01 | 2018-04-11 |
| Krill Oil Study Compared to Fish Oil Krill oil, Fish Oil - Healthy Volunteers | Not applicable | Completed | University of Manitoba | 24 | 2011-05-01 | 2012-11-22 |
| Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China InFat™ based infant formula, Standard vegetable oil based infant formula - Health Behavior, Personal Satisfaction | Not applicable | Completed | Enzymotec | 171 | 2011-05-01 | 2014-02-13 |
| The Effects of Dietary Palmitic Acid Triacylglyceride Position on Intestinal Parameters in Infants (InFat_005) InFat™ based infant formula, Standard vegetable oil based infant formula - Health Behavior, Disorder of Growth and Development | Not applicable | Completed | Enzymotec | 30 | 2010-04-01 | 2011-05-17 |
| Tolerance and Efficacy of Wondersun Infant Formula in Formula-fed Chinese Term Infants Infant formula, Breast feeding - Infant Nutrition | Phase 4 | Completed | Sun Yat-sen University | 75 | 2010-02-01 | 2017-06-08 |
| The Effects of Dietary Palmitic Acid Triacylglyceride Position on Bone Strength Parameters in Infants InFat™ based infant formula, Standard vegetable oil based infant formula - Personal Satisfaction | Not applicable | Completed | Enzymotec | 94 | 2009-02-01 | 2011-02-24 |
| Effects of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants Infant formula feeding (InFat™), Control - Healthy | Phase 4 | Terminated | Enzymotec | 80 | 2008-09-01 | 2011-06-07 |
| The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment Phosphatidylserine-Omega3 (SharpPS™-Gold) - Memory Impairment | Phase 4 | Completed | Enzymotec | 18 | 2008-09-01 | 2010-03-30 |
| Study to Assess the Efficacy of Cognitex Cognitex - Elderly, Memory Impairment | Phase 4 | Completed | Tel-Aviv Sourasky Medical Center | 30 | 2008-08-01 | 2010-04-20 |
| PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children PS-Omega3 conjugate supplementation, placebo - ADHD | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 45 | 2008-07-01 | 2008-06-18 |
| The Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment PS-Omega3, Placebo - Age Associated Memory Impairment | Phase 4 | Completed | Enzymotec | 157 | 2007-04-01 | 2010-01-05 |
| The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder Phosphatidylserine-Omega3, Colored cellulose tainted with fishy odor - Attention Deficit/Hyperactivity Disorder (ADHD) | Phase 2 | Completed | Enzymotec | 200 | 2007-03-01 | 2014-03-12 |
| Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels Plant sterols esters, placebo - Dyslipidemia | Phase 4 | Completed | Enzymotec | 91 | 2007-03-01 | 2012-01-13 |
Attention Deficit Disorder with Hyperactivity (4) · Health Behavior (2) · Memory Disorders (2) · Personal Satisfaction (2) · Autistic Disorder (1) · Breast Milk Expression (1) · Cognitive Dysfunction (1) · Dyslipidemias (1) · Hypercholesterolemia (1) · Hypertriglyceridemia (1) · Impulsive Behavior (1) · Spasm (1)
Cellulose (1) · Fish Oils (1) · Infant Formula (1) · Lactation (1) · Omacor (1) · Phosphatidylserines (1)
Israel (11) · United States (4) · China (3) · Canada (1)
Yuming Chen, PhD (2) · Abraham Weizman, MD (1) · Amos Korczyn, MD (1) · Arie Riskin, MD (1) · Dan Nemet, MD (1) · David S Krakow, M.D (1) · Dror Harats, M.D. (1) · Eric Hollander, M.D. (1) · Jeffrey Newcorn, MD (1) · Lenard A Adler, M.D (1) · Michael Banov, M.D (1) · Michael R Liebowitz, M.D (1) · Nachum Vaisman, Prof' (1) · Nachum Vaisman, Professor (1) · Veronica Vakhapova, MD (1)
PMID 20617456, PMID 21711517, PMID 21807480, PMID 22432687, PMID 23201699, PMID 24304605, PMID 24942975, PMID 26334255, PMID 26537218